The short version
What teams need to understand
- Pharmacovigilance systems must ensure personnel remain competent through retraining and continuous learning.
- Retraining must be triggered by SOP changes, regulatory updates, audit findings, and performance issues.
- Competency must be demonstrated through training completion, assessment, and performance outcomes.
- Training programmes must evolve based on findings, metrics, and regulatory expectations.
- Retraining activities must be documented and tracked.
- Inspection-ready evidence must demonstrate that training is updated, effective, and supports ongoing competence.
Regulatory expectation
What regulators expect
Each expectation should be supported by controlled documentation, traceable records, clear ownership, and evidence that the process works in practice.
- Personnel must remain competent over time.
- Retraining must occur following significant changes.
- Training effectiveness must be assessed.
- Training programmes must be updated based on findings.
- Training must support continuous improvement of the PV system.
Why it matters
What this means in practice
Inspectors assess whether pharmacovigilance systems ensure ongoing competence through retraining and continuous improvement. They review retraining triggers, competency evidence, training updates, and whether training programmes evolve based on audits, metrics, and regulatory changes.
Questions this page answers
Inspection evidence
Evidence teams should be able to show
Retraining Records
- Training completion following SOP updates
- Retraining after audit findings or CAPA
- Evidence of retraining following regulatory changes
- Documentation of retraining completion timelines
Competency Assessment Evidence
- Knowledge checks or quiz results
- Assessment scores or certification outcomes
- Manager verification of competence
- Evidence of correct task performance post-training
Training Update and Improvement Records
- Updates to training materials following process changes
- Revision of training content based on audit findings
- Continuous improvement actions linked to training gaps
- Evidence of training programme evolution
CAPA and Training Linkage
- Training updates triggered by CAPA
- Corrective actions requiring retraining
- Documentation linking findings to training improvements
- Verification that training changes address root causes
Training Effectiveness Monitoring
- Review of training outcomes and performance metrics
- Reduction in errors or deviations following retraining
- Trend analysis of training effectiveness
- Feedback from trainees or managers
Regulatory Basis (Primary Sources)
- GVP Module I - requirement for competent personnel and continuous oversight of competence
- GVP Module II - requirement for maintaining effective PV system documentation and processes
- ICH E2D - requirement for trained and competent staff managing safety data
- MHRA GPvP guidance - expectations for training updates and competence
- FDA pharmacovigilance guidance - requirement for maintaining effective training and competence
Typical Inspection Questions (What Inspectors Ask)
- What triggers retraining in your organisation?
- How do you ensure staff remain competent?
- Show me retraining following this SOP update.
- How do you assess training effectiveness?
- How do you improve your training programme over time?
Common failure patterns
What good looks like
- Clear retraining triggers linked to SOP, regulatory, and audit changes.
- Documented retraining with evidence of completion.
- Assessment of competency following training.
- Training updates aligned with system improvements.
- Continuous improvement of the training programme.
How teams operationalise it
- Define retraining triggers within the training SOP.
- Schedule retraining following SOP updates or audit findings.
- Assess competency using quizzes, checks, or manager verification.
- Update training materials based on regulatory or operational changes.
- Monitor training effectiveness through performance metrics.
- Ensure continuous improvement of training processes.
From expectation to working control
Find the documentation that supports this work
Review the related toolkit to understand its purpose, included files, and how it supports this regulatory expectation.
Frequently asked questions
When is retraining required in pharmacovigilance?
Retraining is required following SOP updates, regulatory changes, audit findings, CAPA, or when performance issues indicate a need for additional training.
How is competency assessed in pharmacovigilance?
Competency is assessed through training completion records, knowledge checks, assessments, and verification that individuals can perform their tasks correctly.
Do inspectors review retraining in pharmacovigilance?
Yes. Inspectors review whether retraining occurs after changes and whether staff remain competent to perform PV activities.
What is continuous improvement in PV training?
Continuous improvement involves updating training programmes based on audit findings, regulatory changes, and performance data to ensure ongoing competence.
How do you ensure staff remain competent over time?
By combining initial training, periodic refresher training, retraining after changes, and ongoing assessment of performance and knowledge.
What happens if retraining is not performed?
Failure to retrain staff can result in inspection findings due to lack of competence and increased compliance risk.
Source boundary
Regulatory sources
These primary sources inform this structured interpretation. Always confirm current requirements against the original source and the requirements applicable to your organisation, product, and jurisdiction.
European Medicines Agency (EMA)
Guideline on good pharmacovigilance practices (GVP) - Module I
View sourceGuideline on good pharmacovigilance practices (GVP) - Module II
View source
FDA
21 CFR Part 11 - Electronic Records
View source
ICH
Post-Approval Safety Data Management (E2D)
View source
MHRA
Good Pharmacovigilance Practice (GPvP)
View source